Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
PharMerica CORP (PMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/18/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/11/2017 4 WEISHAR GREGORY S (CEO) has filed a Form 4 on PharMerica CORP
Txns: Gifted 51,282 shares @ $0
Disposed/sold 440,001 shares @ $29.25, valued at $12.9M
Sold 519,589 shares @ $29.25, valued at $15.2M
Sold 1,500 shares @ $29.25, valued at $43.9k
Granted 146,521 options to buy @ $0
Disposed/sold 146,521 options to buy @ $0
Disposed/sold 182,801 options to buy @ $10.84, valued at $2M
12/08/2017 4 MEYERS GEOFFREY G (Director) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 59,240 shares @ $29.25, valued at $1.7M
12/08/2017 4 OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 57,275 shares @ $29.25, valued at $1.7M
12/08/2017 4 LEPORE PATRICK G (Director) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 29,570 shares @ $29.25, valued at $864.9k
12/08/2017 4 DORR MARJORIE W (Director) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 58,689 shares @ $29.25, valued at $1.7M
12/08/2017 4 Dahl W Robert Jr (Director) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 56,742 shares @ $29.25, valued at $1.7M
12/08/2017 4 COLLINS FRANK E (Director) has filed a Form 4 on PharMerica CORP
Txns: Gifted 1,161 shares @ $0
Disposed/sold 60,262 shares @ $29.25, valued at $1.8M
12/08/2017 4 Vishnubhatla Suresh (EVP, LTC Operations) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 67,031 shares @ $29.25, valued at $2M
Granted 41,758 options to buy @ $0
Disposed/sold 41,758 options to buy @ $0
Disposed/sold 20,719 options to buy @ $10.84, valued at $224.6k
12/08/2017 4 Tomassetti Berard (SVP and CAO) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 14,599 shares @ $29.25, valued at $427k
Granted 8,906 options to buy @ $0
Disposed/sold 8,906 options to buy @ $0
Disposed/sold 2,964 options to buy @ $10.84, valued at $32.1k
12/08/2017 4 McKay Robert A (SVP Purchasing,Trade Relations) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 89,314 shares @ $29.25, valued at $2.6M
12/08/2017 4 Dries Robert E. (CFO) has filed a Form 4 on PharMerica CORP
Txns: Disposed/sold 28,226 shares @ $29.25, valued at $825.6k
Granted 28,226 options to buy @ $0
Disposed/sold 28,226 options to buy @ $0
12/08/2017 4 Caneris Thomas A (SVP, GC and Secretary) has filed a Form 4 on PharMerica CORP
Txns: Gifted 2,753 shares @ $0
Disposed/sold 87,023 shares @ $29.25, valued at $2.5M
Granted 29,672 options to buy @ $0
Disposed/sold 29,672 options to buy @ $0
Disposed/sold 9,588 options to buy @ $10.84, valued at $103.9k
12/08/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/07/2017 8-K Resignation/termination of a director
Docs: "Amended and Restated Certificate of Incorporation of PharMerica Corporation",
"Amended and Restated Bylaws of PharMerica Corporation",
"KKR Completes Acquisition of PharMerica"
12/07/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/21/2017 4 McKay Robert A (SVP Purchasing,Trade Relations) has filed a Form 4 on PharMerica CORP
Txns: Granted 22,730 shares @ $0
Paid exercise price by delivering 19,719 shares @ $29.1, valued at $573.8k
11/09/2017 8-K Quarterly results
Docs: "LOUISVILLE, Ky. (November 9, 2017"
11/09/2017 BW PharMerica Reports Third Quarter 2017 Results
11/09/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/09/2017 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "PharMerica Announces Approval of Merger by Stockholders"
10/27/2017 8-K Quarterly results
10/27/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/03/2017 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/06/2017 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
08/28/2017 8-K Quarterly results
08/28/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger among PharMerica Corporation, Phoenix Parent Holdings Inc. and Phoenix Merger Sub Inc.",
"Antitrust Support Side Letter among PharMerica Corporation, KKR Americas Fund XII L.P. and Walgreens Boots Alliance, Inc."
08/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy